NAT10 and colorectal carcinoma: Since ERRFI1 is a driver of 5-FU resistance in CRC [17] and the NAT10-mediated epigenetic modification of mRNA is reversible and responds rapidly to cellular stress, we evaluated whether 5-FU treatment affects the NAT10-ERRFI1 axis.